News Releases & Statements

News Releases & Statements

The

The Leukemia & Lymphoma Society Earns a Four-Star Rating From Charity Navigator

Posted On: November 16, 2022

Rye Brook, N.Y. - The Leukemia & Lymphoma Society is proud to announce that its strong financial health and ongoing accountability and transparency have earned LLS a Four-Star Rating from Charity Navigator. Read More

FDA-Approval-Misc

LLS Applauds FDA Approval of New Treatment Option for Pediatric Patients with Hodgkin Lymphoma

Posted On: November 11, 2022 Read More
FDA Approval Misc

Crucial LLS Support Drives Approval of New Precision Medicine for Rare Group of Blood Diseases

Posted On: November 4, 2022 Read More
Shred for Red

Shred For Red: An Unstoppable Community Hits the Slopes to End Blood Cancer

Posted On: October 31, 2022 Read More
Breaking News Myeloma

FDA Broadens Treatment Options for Relapsed/Refractory Multiple Myeloma

Posted On: October 27, 2022 Read More
Fast Company

The Leukemia & Lymphoma Society Named in Fast Company’s Second Annual List of “Brands That Matter”

Posted On: October 24, 2022

[Rye Brook, NY], October 25, 2022 – Fast Company announced today its second annual Brands That Matter list, honoring brands that communicate and demonstrate brand purpose. These companies and nonprofits have achieved relevance through cultural impact and social engagement and authentically communicated their missions and ideals.

Read More
Kite,

Kite, a Gilead Company Named Presenting Sponsor of Celebration & Community for LLS’s National Light The Night Events

Posted On: October 21, 2022

Rye Brook, NY, (October 24, 2022) – The Leukemia & Lymphoma Society (LLS) announced today that Kite, a Gilead Company has signed a two-year agreement to join LLS as the National Presenting Sponsor of Celebration & Communit Read More

FDA Approval Misc

Study from The Leukemia & Lymphoma Society Provides New Information on How Blood Cancer Patients Respond to COVID-19 Vaccines

Posted On: October 20, 2022

LLS thanks the family of Michael Garil, and his parents Bernie and Ethel Garil, for their support of LLS and the blood cancer community. The National Patient Registry is a project of the Michael J. Garil Patient Data Collective, which was created to honor their son’s memory.

Read More

Media Requests

Please send all media-related inquiries and interview requests to mediarelations@lls.org.  An LLS representative will respond as soon as possible.